The redefinition of mental health

The definitions of mental illness are being expanded in the interests of pharmaceutical profits – but the backlash has begun. James McKeigue reports.

What's happened?

The American Psychiatric Association (APA) is revising its manual on diagnosing mental health. The new edition is known as DSM-5. Because mental illness has no physical markers, the manual attempts to define characteristics that patients share. The guidelines are used by most mental health professionals in America, the world's largest health market, to select treatment. It's a staple of America's $700bn-a-year health insurance industry, as several insurers will only pay for treatment if the disease is diagnosed by the guidelines.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
James McKeigue

James graduated from Keele University with a BA (Hons) in English literature and history, and has a certificate in journalism from the NCTJ. James has worked as a freelance journalist in various Latin American countries.He also had a spell at ITV, as welll as wring for Television Business International and covering the European equity markets for the Forbes.com London bureau. James has travelled extensively in emerging markets, reporting for international energy magazines such as Oil and Gas Investor, and institutional publications such as the Commonwealth Business Environment Report. He is currently the managing editor of LatAm INVESTOR, the UK's only Latin American finance magazine.